title: Archaeosomes made of Halorubrum tebenquichense total polar lipids: a new source of adjuvancy.
abstract: BACKGROUND
  Archaeosomes (ARC), vesicles prepared from total polar lipids (TPL) extracted from selected genera and species from the Archaea domain, elicit both antibody and cell-mediated immunity to the entrapped antigen, as well as efficient cross priming of exogenous antigens, evoking a profound memory response. Screening for unexplored Archaea genus as new sources of adjuvancy, here we report the presence of two new Halorubrum tebenquichense strains isolated from grey crystals (GC) and black mood (BM) strata from a littoral Argentinean Patagonia salt flat. Cytotoxicity, intracellular transit and immune response induced by two subcutaneous (sc) administrations (days 0 and 21) with BSA entrapped in ARC made of TPL either form BM (ARC-BM) and from GC (ARC-GC) at 2% w/w (BSA/lipids), to C3H/HeN mice (25 microg BSA, 1.3 mg of archaeal lipids per mouse) and boosted on day 180 with 25 microg of bare BSA, were determined.
  
  
  RESULTS
  DNA G+C content (59.5 and 61.7% mol BM and GC, respectively), 16S rDNA sequentiation, DNA-DNA hybridization, arbitrarily primed fingerprint assay and biochemical data confirmed that BM and GC isolates were two non-previously described strains of H. tebenquichense. Both multilamellar ARC mean size were 564 +/- 22 nm, with -50 mV zeta-potential, and were not cytotoxic on Vero cells up to 1 mg/ml and up to 0.1 mg/ml of lipids on J-774 macrophages (XTT method). ARC inner aqueous content remained inside the phago-lysosomal system of J-774 cells beyond the first incubation hour at 37 degrees C, as revealed by pyranine loaded in ARC. Upon subcutaneous immunization of C3H/HeN mice, BSA entrapped in ARC-BM or ARC-GC elicited a strong and sustained primary antibody response, as well as improved specific humoral immunity after boosting with the bare antigen. Both IgG1 and IgG2a enhanced antibody titers could be demonstrated in long-term (200 days) recall suggesting induction of a mixed Th1/Th2 response.
  
  
  CONCLUSIONS
  We herein report the finding of new H. tebenquichense non alkaliphilic strains in Argentinean Patagonia together with the adjuvant properties of ARC after sc administration in mice. Our results indicate that archaeosomes prepared with TPL from these two strains could be successfully used as vaccine delivery vehicles.
authors.affiliation: Programa de Nanomedicinas, Universidad Nacional de Quilmes, Roque Saenz Peña 352, Bernal, Buenos Aires, Argentina. rgonzalez@unq.edu.ar
authors.forename: Raul O
authors.initials: RO
authors.lastname: Gonzalez
authors.forename: Leticia H
authors.initials: LH
authors.lastname: Higa
authors.forename: Romina A
authors.initials: RA
authors.lastname: Cutrullis
authors.forename: Marcos
authors.initials: M
authors.lastname: Bilen
authors.forename: Irma
authors.initials: I
authors.lastname: Morelli
authors.forename: Diana I
authors.initials: DI
authors.lastname: Roncaglia
authors.forename: Ricardo S
authors.initials: RS
authors.lastname: Corral
authors.forename: Maria Jose
authors.initials: MJ
authors.lastname: Morilla
authors.forename: Patricia B
authors.initials: PB
authors.lastname: Petray
authors.forename: Eder L
authors.initials: EL
authors.lastname: Romero
mesh_terms: D000276:Adjuvants, Immunologic / Q000737:chemistry*; D000818:Animals; D000917:Antibody Formation; D001482:Base Composition; D002522:Chlorocebus aethiops; D019641:DNA, Archaeal / Q000235:genetics; D005260:Female; D055352:Halorubrum / Q000737:chemistry* / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D007074:Immunoglobulin G / Q000097:blood / Q000276:immunology; D008055:Lipids / Q000737:chemistry / Q000276:immunology*; D008081:Liposomes / Q000737:chemistry / Q000276:immunology*; D051379:Mice; D008809:Mice, Inbred C3H; D010802:Phylogeny; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D014709:Vero Cells
chemical_list: D000276:Adjuvants, Immunologic; D019641:DNA, Archaeal; D007074:Immunoglobulin G; D008055:Lipids; D008081:Liposomes; D012336:RNA, Ribosomal, 16S
references.citation: J Liposome Res. 2002 Nov;12(4):353-72
references.pmid: 12519630
references.citation: Syst Appl Microbiol. 1983;4(2):184-92
references.pmid: 23194591
references.citation: Anal Biochem. 1976 May 7;72:248-54
references.pmid: 942051
references.citation: J Immunol. 2000 Nov 1;165(9):5177-85
references.pmid: 11046050
references.citation: Vaccine. 2008 Apr 16;26(17):2043-55
references.pmid: 18343538
references.citation: Int J Toxicol. 2003 Jan-Feb;22(1):9-23
references.pmid: 12573945
references.citation: Ann Microbiol (Paris). 1976 Feb-Mar;127A(2):223-35
references.pmid: 786103
references.citation: Biochim Biophys Acta. 1993 Jul 21;1169(1):46-53
references.pmid: 8334149
references.citation: Vaccine. 2005 May 2;23(24):3210-22
references.pmid: 15837222
references.citation: J Biol Chem. 2001 Jul 20;276(29):27266-71
references.pmid: 11373291
references.citation: Int J Syst Bacteriol. 1997 Jul;47(3):853-7
references.pmid: 9226918
references.citation: Anal Biochem. 1980 May 1;104(1):10-4
references.pmid: 6892980
references.citation: Infect Immun. 2000 Jan;68(1):54-63
references.pmid: 10603368
references.citation: J Mol Biol. 1962 Jul;5:109-18
references.pmid: 14470099
references.citation: Appl Environ Microbiol. 2004 Nov;70(11):6678-85
references.pmid: 15528534
references.citation: Biosci Biotechnol Biochem. 1999 Jun;63(6):969-72
references.pmid: 10427681
references.citation: J Drug Target. 2003;11(8-10):515-24
references.pmid: 15203920
references.citation: Vaccine. 2004 Jun 2;22(17-18):2154-62
references.pmid: 15149772
references.citation: Infect Immun. 2003 Feb;71(2):591-6
references.pmid: 12540534
references.citation: J Bacteriol. 1955 Oct;70(4):484-5
references.pmid: 13263323
references.citation: Int J Syst Evol Microbiol. 2002 Jan;52(Pt 1):149-155
references.pmid: 11837297
references.citation: Int J Syst Bacteriol. 1997 Jan;47(1):73-7
references.pmid: 8995805
references.citation: Int J Syst Evol Microbiol. 2004 Jul;54(Pt 4):1213-1216
references.pmid: 15280294
references.citation: Glycobiology. 2008 Jul;18(7):559-65
references.pmid: 18450974
references.citation: Experientia. 1993 Dec 15;49(12):1027-36
references.pmid: 8270029
references.citation: Chem Phys Lipids. 2003 Dec;126(2):225-32
references.pmid: 14623456
references.citation: Anal Biochem. 1977 Aug;81(2):461-6
references.pmid: 907108
references.citation: J Immunol Methods. 1992 Mar 4;147(2):153-65
references.pmid: 1548398
references.citation: Biochemistry. 1990 May 22;29(20):4929-39
references.pmid: 2163672
references.citation: Eur J Biochem. 1970 Jan;12(1):133-42
references.pmid: 4984993
references.citation: Int J Syst Evol Microbiol. 2006 Jul;56(Pt 7):1583-1588
references.pmid: 16825633
references.citation: Biochim Biophys Acta. 1990 May 24;1024(2):352-66
references.pmid: 2162207
references.citation: Infect Immun. 2002 Apr;70(4):1957-64
references.pmid: 11895959
references.citation: Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7
references.pmid: 271968
references.citation: J Lipid Res. 2004 Jan;45(1):194-201
references.pmid: 13130126
references.citation: J Immunol. 2001 Feb 1;166(3):1885-93
references.pmid: 11160236
references.citation: Adv Drug Deliv Rev. 2005 Jan 10;57(3):325-31
references.pmid: 15560944
references.citation: Biochim Biophys Acta. 1996 May 23;1294(2):159-67
references.pmid: 8645734
references.citation: Evolution. 1985 Jul;39(4):783-791
references.pmid: 28561359
references.citation: Extremophiles. 1999 Nov;3(4):253-7
references.pmid: 10591015
references.citation: FEMS Microbiol Lett. 1997 Sep 1;154(1):17-22
references.pmid: 9297816
references.citation: Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
references.pmid: 7984417
references.citation: Glycobiology. 2009 Mar;19(3):267-76
references.pmid: 19029107
references.citation: Can J Microbiol. 1976 Apr;22(4):587-91
references.pmid: 1260548
references.citation: Nucleic Acids Res. 1997 Dec 15;25(24):4876-82
references.pmid: 9396791
references.citation: Adv Drug Deliv Rev. 2002 Oct 4;54(6):863-70
references.pmid: 12363435
references.citation: Carbohydr Res. 2008 Sep 22;343(14):2349-60
references.pmid: 18667197